Laboratory Models of ALS - The ALS Association
From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis | In Vivo
ALS Animal Models - Disease Models | Target ALS
Gut microbes tune inflammation and lifespan in a mouse model of amyotrophic lateral sclerosis
Working with ALS Mice: Guidelines for Preclinical Testing and Colony Management
SOD1-G93A Mouse Model - QPS Neuropharmacology
In ALS Animal Model, Engineered Neural Cells Delay Disease, Extend Life
Frontiers | Mouse Models of C9orf72 Hexanucleotide Repeat Expansion in Amyotrophic Lateral Sclerosis/ Frontotemporal Dementia
Figure 4 from Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies. | Semantic Scholar
Rodent Amyotrophic Lateral Sclerosis (ALS) Model - Creative Biolabs
Frontiers | Circadian Rhythm Dysfunction Accelerates Disease Progression in a Mouse Model With Amyotrophic Lateral Sclerosis
Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS–FTD-linked UBQLN2 mutations | PNAS
Drug target validation in mouse models of ALS. (A) Comparison between... | Download Scientific Diagram
A major step towards the cure of sporadic ALS | The University of Tokyo
IJMS | Free Full-Text | Brain Protease Activated Receptor 1 Pathway: A Therapeutic Target in the Superoxide Dismutase 1 (SOD1) Mouse Model of Amyotrophic Lateral Sclerosis
Murine Models of Neurodegenerative Diseases - Maze Engineers
Amyotrophic lateral sclerosis (ALS):SOD1 mouse helps researchers identify immune component
AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALS: Molecular Therapy - Methods & Clinical Development
Humanising mice to enable modelling of neurodegenerative diseases | UCL Queen Square Institute of Neurology - UCL – University College London
Boosting the peripheral immune response in the skeletal muscles improved motor function in ALS transgenic mice - ScienceDirect
Figure 3.1 from The neuromuscular transmission of the SOD 1 ( G 93 A ) mouse model of Amyotrophic Lateral Sclerosis | Semantic Scholar
File:ALS animal models.jpg - Wikimedia Commons
Opinion: more mouse models and more translation needed for ALS | Molecular Neurodegeneration | Full Text
Realizing the gains and losses in C9ORF72 ALS/FTD | Nature Neuroscience
IJMS | Free Full-Text | Novel P2X7 Antagonist Ameliorates the Early Phase of ALS Disease and Decreases Inflammation and Autophagy in SOD1-G93A Mouse Model
Identification of novel neuroprotective molecule effective in ALS mouse models | The University of Tokyo
